HBEGF and myeloid sarcoma: Similarly, we detected no expression of HB-EGF by GFAP+ astrocytes in CNS tissue obtained from a patient diagnosed with MS 6 yr ago (Fig. 8a and Supplementary Table 4), matching our observations of decreased HB-EGF expression by astrocytes during late-stage EAE.